Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted?
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Clinical Microbiology and Infection |
| Vol/bind | 28 |
| Udgave nummer | 3 |
| Sider (fra-til) | 456-457 |
| Antal sider | 2 |
| ISSN | 1198-743X |
| DOI |
|
| Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:
The authors have no conflicts of interest to disclose. Dr Mathioudakis was supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC) .
Links
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608423/pdf/main.pdf
Forlagets udgivne version
ID: 345511152